Loading...
Loading...
Ambit Biosciences
AMBI shares jumped 87.56% to $15.38 after Daiichi Sankyo
DSNKY announced its plans to acquire Ambit Biosciences for $15 per share in cash through a tender offer.
Athlon Energy
ATHL shares gained 24.67% to $58.26 after Encana
ECA announced its plans to buy Athlon Energy for $5.93 billion.
Tibco Software
TIBX shares jumped 21.12% to $23.63 after the company agreed to be acquired by Vista Equity Partners for $4.3 billion.
DreamWorks Animation SKG
DWA rose 19.99% to $26.83 on rumor of Softbank
SFTBY $32.00 per share bid.
Alimera Sciences
ALIMLoading...
Loading...
shares rose 15.74% to $5.70 after the company confirmed the FDA approval for ILUVIEN. The company expected to begin selling ILUVIEN in the US during the first quarter of 2015.
AMAG Pharmaceuticals
AMAG gained 15.62% to $26.80 after the company agreed to acquire Lumara Health for $675 million in a cash and stock deal.
Exelixis
EXEL shares climbed 10.89% to $1.73 after the company reported positive results from Phase 3 pivotal trial of Cobimetinib in combination with Vemurafenib in patients with BRAF V600 Mutation-positive advanced melanoma.
Endocyte
ECYT shares rose 7.63% to $7.90 after the company reported that Phase 2b results showed improved survival in Adenocarcinoma NSCLC patients treated with Vintafolide.
pSivida
PSDV jumped 6.01% to $4.55 after the company confirmed the FDA approval for ILUVIEN.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in